ARIA: ARIAD PHARMACEUTICALS INC Real-Time Headlines

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

Symbol	Value	Change	Percentage Change
DJIA	10,023.42	17.46	0.17%
NASDAQ	2,112.44	7.12	0.34%
S&P 500	1,069.30	2.67	0.25%

Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Learn More

Get the FREE DailyFinance iPhone application

ARIAD PHARMACEUTICALS INC

ARIA

Stock price

2.17 0.19 9.60%

as of 04:00 PM EST on 11/06/2009 in USD (NASDAQ Delay: 15 mins.)
Extended Hours

2.43 0.26 11.98%

as of 08:31 AM EST on 11/09/09

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: ARIA

ARIAD PHARMACEUTICALS INC Real-Time Headlines

Customize
Monday, November 09, 2009

Sunrise, Kohlberg: Early Volume Plays

8:41:15 AM | TheStreet.com

JP Morgan Upgrades Ariad Pharmaceuticals (ARIA) to Overweight

8:36:48 AM View all Related Articles > | StreetInsider.com

Ariad Upgraded, Xenoport Drug Delayed: BioBuzz

7:51:54 AM | TheStreet.com

Ariad Pharmaceuticals upgraded to Overweight at JP Morgan

7:33:34 AM | Theflyonthewall.com

Friday, November 6, 2009

Ariad's 3Q loss widens slightly on costs

11/6/09 View all Related Articles > | AP ONLINE

Thursday, November 5, 2009

ARIAD Pharma (ARIA) Posts Q3 Loss of 21c, Misses Views by 3c

11/5/09 | StreetInsider.com

SEC Filing: Current Event

11/5/09 | Thomson Financial

Ariad Pharmaceuticals affirms SUCCEED trial on track for full enrollment

11/5/09 | Theflyonthewall.com

Ariad Pharmaceuticals reports Q3 EPS (21c) vs. consensus of (18c)

11/5/09 | Theflyonthewall.com

ARIAD Reports Third Quarter 2009 Development Progress and Financial Results

11/5/09 | Business Wire

Monday, November 2, 2009

ARIAD’s AP24534 Featured in Cancer Cell Publication as a Potential First-in-Class Pan BCR-ABL Inhibitor

11/2/09 | Business Wire

Tuesday, October 27, 2009

ARIAD to Present at the Oppenheimer 20th Annual Healthcare Conference

10/27/09 | Business Wire

Thursday, October 22, 2009

ARIAD to Webcast Conference Call on Third Quarter 2009 Financial Results

10/22/09 | Business Wire

Tuesday, October 13, 2009

3 Stocks Ready to Roar

10/13/09 | The Motley Fool

Thursday, October 8, 2009

Ariad Pharmaceuticals initiated with a Hold at Brean Murray

10/8/09 View all Related Articles > | Theflyonthewall.com

Monday, October 5, 2009

SEC Filing: Insider Buy/Sell

10/5/09 | Thomson Financial

Wednesday, September 23, 2009

SEC Filing: Current Event

9/23/09 | Thomson Financial

Monday, September 21, 2009

ARIAD Announces Clinical Data from Phase 1 Study of Its Investigational mTOR Inhibitor, Ridaforolimus, in Combination with Bevacizumab

9/21/09 | Business Wire

Tuesday, September 15, 2009

Ariad Pharmaceuticals, Inc. Says Independent Experts Positive on Cancer Drug

9/15/09 View all Related Articles > | BioSpace

Monday, September 14, 2009

Ariad Pharma

9/14/09 View all Related Articles > | Briefing.com

Top Day Trader Alerts (ARIA, DPTR, ETFC, FSLR, MOS, POT, SLXP, S)

9/14/09 | 24/7 Wall Street

ARIAD Announces Result of First Interim Analysis of Phase 3 Succeed Trial of Oral Ridaforolimus, Its Investigational mTOR Inhibitor, in Metastatic Sarcomas

9/14/09 | Business Wire

Friday, September 4, 2009

Tomorrow's Monster Stock?

9/4/09 | The Motley Fool

Wednesday, September 2, 2009

ARIAD to Present at the Rodman & Renshaw Annual Healthcare Conference

9/2/09 | Business Wire

Friday, August 28, 2009

InvestorSoup.com Issues Technical Trading Outlook for ARIAD Pharmaceuticals Inc.

8/28/09 | GlobeNewswire

Wednesday, August 26, 2009

6 Stocks Attracting Top Investors

8/26/09 | The Motley Fool

Monday, August 24, 2009

SEC Filing: Greater than or Equal to 5% Acquisition

8/24/09 View all Related Articles > | Thomson Financial

Pre-Market Movers: Ariad Pharmaceuticals, Advanced Micro Devices

8/24/09 View all Related Articles > | FOXBusiness.com

Top Day Trader Alerts (AMD, ARIA, SIRI, SBGI, CHIC, SHLD)

8/24/09 | 24/7 Wall Street

ARIAD And Its Co-Plaintiffs Announce That the Court of Appeals Granted Their Petition for Rehearing En Banc In the Lilly NF-kB Patent Lawsuit

8/24/09 | Business Wire

Sunday, August 23, 2009

What's Brewing At Ariad Pharma?

8/23/09 | RTTNews

Tuesday, August 18, 2009

Stocks Showing Unusually Heavy Volume - Dendreon Corp, Vasogen Inc, Vitesse Semiconductor, ARIAD Pharmaceuticals Inc

8/18/09 View all Related Articles > | Schaeffer's Investment Research

Monday, August 17, 2009

Movers roundup: Ariad Pharmaceuticals, US Bancorp

8/17/09 | AP ONLINE

Ariad Pharmaceuticals shares rise on upbeat note

8/17/09 View all Related Articles > | AP ONLINE

Wednesday, August 12, 2009

Biotechnology Industry Hits On The Capital Markets (ISPH, ARIA, MITI, MAPP)

8/12/09 | Investopedia

Monday, August 10, 2009

ARIAD Pharmaceuticals Inc. Reports Operating Results (10-Q)

8/10/09 | GuruFocus

SEC Filing: Quarterly Financials

8/10/09 | Thomson Financial

Saturday, August 8, 2009

Weekly CEO Buys Highlight: Citigroup Inc, ARIAD Pharmaceuticals Inc, Bruker BioSciences Corp, ...

8/8/09 | GuruFocus

Monday, August 3, 2009

Ariad Pharmaceuticals to offer 17 million shares

8/3/09 View all Related Articles > | AP ONLINE

SEC Filing: Current Event

8/3/09 View all Related Articles > | Thomson Financial

1 <Next>
Monday, November 09, 2009

Sunrise, Kohlberg: Early Volume Plays

8:41:15 AM | TheStreet.com

Ariad Upgraded, Xenoport Drug Delayed: BioBuzz

7:51:54 AM | TheStreet.com

Ariad Pharmaceuticals upgraded to Overweight at JP Morgan

7:33:34 AM | Theflyonthewall.com

Ariad Pharmaceuticals upgraded to Overweight from Neutral at JP Morgan

6:28:58 AM | Theflyonthewall.com

Friday, November 6, 2009

Ariad's 3Q loss widens slightly on costs

11/6/09 | AP ONLINE

Thursday, November 5, 2009

SEC Filing: Current Event

11/5/09 | Thomson Financial

Ariad Pharmaceuticals affirms SUCCEED trial on track for full enrollment

11/5/09 | Theflyonthewall.com

Ariad Pharmaceuticals reports Q3 EPS (21c) vs. consensus of (18c)

11/5/09 | Theflyonthewall.com

Tuesday, October 13, 2009

3 Stocks Ready to Roar

10/13/09 | The Motley Fool

Thursday, October 8, 2009

Ariad Pharmaceuticals initiated with a Hold at Brean Murray

10/8/09 | Theflyonthewall.com

Monday, October 5, 2009

SEC Filing: Insider Buy/Sell

10/5/09 | Thomson Financial

Wednesday, September 23, 2009

SEC Filing: Current Event

9/23/09 | Thomson Financial

Monday, September 14, 2009

Ariad Pharma

9/14/09 View all News Related Articles > | Briefing.com

Friday, September 4, 2009

Tomorrow's Monster Stock?

9/4/09 | The Motley Fool

Wednesday, August 26, 2009

6 Stocks Attracting Top Investors

8/26/09 | The Motley Fool

Monday, August 24, 2009

SEC Filing: Greater than or Equal to 5% Acquisition

8/24/09 View all News Related Articles > | Thomson Financial

Pre-Market Movers: Ariad Pharmaceuticals, Advanced Micro Devices

8/24/09 View all News Related Articles > | FOXBusiness.com

Sunday, August 23, 2009

What's Brewing At Ariad Pharma?

8/23/09 | RTTNews

Tuesday, August 18, 2009

Stocks Showing Unusually Heavy Volume - Dendreon Corp, Vasogen Inc, Vitesse Semiconductor, ARIAD Pharmaceuticals Inc

8/18/09 | Schaeffer's Investment Research

Monday, August 17, 2009

Movers roundup: Ariad Pharmaceuticals, US Bancorp

8/17/09 | AP ONLINE

Ariad Pharmaceuticals shares rise on upbeat note

8/17/09 | AP ONLINE

Wednesday, August 12, 2009

Biotechnology Industry Hits On The Capital Markets (ISPH, ARIA, MITI, MAPP)

8/12/09 | Investopedia

Monday, August 10, 2009

ARIAD Pharmaceuticals Inc. Reports Operating Results (10-Q)

8/10/09 | GuruFocus

SEC Filing: Quarterly Financials

8/10/09 | Thomson Financial

Saturday, August 8, 2009

Weekly CEO Buys Highlight: Citigroup Inc, ARIAD Pharmaceuticals Inc, Bruker BioSciences Corp, ...

8/8/09 | GuruFocus

Monday, August 3, 2009

Ariad Pharmaceuticals to offer 17 million shares

8/3/09 | AP ONLINE

SEC Filing: Current Event

8/3/09 View all News Related Articles > | Thomson Financial

Thursday, July 30, 2009

2-Star Stocks Poised to Plunge: Ariad?

7/30/09 | The Motley Fool

Beacon Equity Issues Trading Outlook for Ariad Pharmaceuticals Inc.

7/30/09 | TradingMarkets

Tuesday, July 28, 2009

SEC Filing: Current Event

7/28/09 View all News Related Articles > | Thomson Financial

Ariad posts positive early breast cancer test data

7/28/09 | AP ONLINE

Stocks Showing Unusually Heavy Volume - ARIAD Pharmaceuticals Inc, Syntroleum Corp, OceanFreight Inc

7/28/09 | Schaeffer's Investment Research

Monday, July 27, 2009

LiquidTycoon.com: Ariad Pharmaceuticals, Inc (NASDAQ:ARIA) is the Highest Percentage Gainers Among NASDAQ Stocks During Morning Trading Hours

7/27/09 | TradingMarkets

Wednesday, July 1, 2009

SEC Filing: Greater than or Equal to 5% Acquisition

7/1/09 | Thomson Financial

Monday, June 22, 2009

SEC Filing: Insider Buy/Sell

6/22/09 View all News Related Articles > | Thomson Financial

Monday, June 15, 2009

Top-Rated Stocks That Treat Shareholders Right

6/15/09 | The Motley Fool

Wednesday, June 10, 2009

Biotech Calendar: Key Clinical Trial Dates

6/10/09 | TheStreet.com

Tuesday, June 9, 2009

3 Stocks Ready to Roar

6/9/09 | The Motley Fool

Friday, May 29, 2009

5 Cold Stocks Heating Up

5/29/09 | The Motley Fool

Thursday, May 14, 2009

xtremepicks.com: ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) Xtreme picks of the day!

5/14/09 | TradingMarkets

1 <Next>
Tuesday, September 15, 2009

Ariad Pharmaceuticals, Inc. Says Independent Experts Positive on Cancer Drug

9/15/09 View all Trade Related Articles > | BioSpace

Monday, August 3, 2009

Ariad Pharmaceuticals to offer 17 million shares

8/3/09 View all Trade Related Articles > | Product Design and Development

Tuesday, July 28, 2009

Ariad Pharmaceuticals, Inc. Announces Preliminary Data from Two Ongoing Clinical Trials of Its Investigational mTOR Inhibitor, Ridaforolimus, in Combination with Targeted Drugs; Says Breast Cancer Drug Shows Promise

7/28/09 View all Trade Related Articles > | BioSpace

Monday, July 27, 2009

UPDATE 1-Ariad Pharma says cancer drug shows promise

7/27/09 View all Trade Related Articles > | Interactive Investor - UK

Thursday, May 7, 2009

ARIAD Pharmaceuticals Inc. (ARIA) reports 1st Quarter ending March 2009 inline with estimates

5/7/09 View all Trade Related Articles > | Earnings Whispers

Friday, February 13, 2009

ARIAD Pharmaceuticals Inc. (ARIA) reports 1st Quarter ending March 2009 above estimates

2/13/09 | Earnings Whispers

Thursday, February 12, 2009

ARIAD Pharmaceuticals Inc. (ARIA) reports 4th Quarter ending December 2008 above estimates

2/12/09 | Earnings Whispers

Wednesday, November 12, 2008

Ariad Pharmaceuticals, Inc. To Present at the Markets 5th Annual Healthcare Conference

11/12/08 | PharmaInfo.net - Canada

Friday, October 24, 2008

Ariad Pharmaceuticals, Inc. Presents Preclinical Data on Its Kinase Inhibitor, AP24534, Demonstrating Mechanism-Based Activity in Solid Tumors

10/24/08 View all Trade Related Articles > | PharmaInfo.net - Canada

Ariad Pharmaceuticals, Inc. (ARIA) Presents Preclinical Data on Deforolimus and Bicalutamide in Androgen-Independent Prostate Cancer

10/24/08 View all Trade Related Articles > | Biocompare

Thursday, October 23, 2008

Ariad Pharmaceuticals, Inc. to Webcast Conference Call on Third Quarter 2008 Financial Results

10/23/08 | PharmaInfo.net - Canada

Thursday, October 16, 2008

Ariad Pharmaceuticals, Inc. to Present Data on Deforolimus and AP24534 at 20th Annual Symposium

10/16/08 View all Trade Related Articles > | PharmaInfo.net - Canada

Wednesday, October 8, 2008

Ariad Pharmaceuticals names two new board members

10/8/08 | Datamonitor

Monday, September 22, 2008

Ariad Pharmaceuticals, Inc. Announces Court Rulings Regarding NF-?B Patent Lawsuit with Amgen

9/22/08 View all Trade Related Articles > | PharmaInfo.net - Canada

Friday, September 12, 2008

Ariad Pharmaceuticals to merge with Ariad Gene Therapeutics

9/12/08 View all Trade Related Articles > | Interactive Investor - UK

Thursday, August 7, 2008

Ariad Pharmaceuticals initiates Phase II endometrial cancer trial

8/7/08 View all Trade Related Articles > | Datamonitor

Ariad Pharmaceuticals, Inc. Q2 Loss Narrower Than Expected; COO Resigns

8/7/08 View all Trade Related Articles > | BioSpace

Tuesday, May 27, 2008

Ariad Pharmaceuticals Inc. Q1 2008 Earnings Call Transcript

5/27/08 | smallcapcenter.com

Wednesday, February 13, 2008

Ariad Pharmaceuticals names Pascoe to new position of operating chief

2/13/08 View all Trade Related Articles > | smallcapcenter.com

Tuesday, February 12, 2008

ARIAD Pharmaceuticals, Incorporated (ARIA) Chief Executive

2/12/08 | smallcapcenter.com

Thursday, February 7, 2008

Ariad Pharmaceuticals Q4 Loss Widens; Guides FY08 - Quick Facts

2/7/08 | smallcapcenter.com

Tuesday, February 5, 2008

Ariad Pharmaceuticals Continues Slump

2/5/08 | smallcapcenter.com

Wednesday, November 28, 2007

Ahead of the Bell: Ariad Pharmaceuticals

11/28/07 View all Trade Related Articles > | PharmiWeb.com - UK

Saturday, November 10, 2007

Cowen & Co Changes EPS Estimate of ARIAD PHARMACEUTICALS INC: Current Recommendation is Outperform

11/10/07 | smallcapcenter.com

Wednesday, November 7, 2007

Ariad Pharmaceuticals, Inc. News, Search Jobs, Events

11/7/07 | BioSpace

Ariad Pharmaceuticals' 3rd - Quarter Loss Narrows on Higher Licensing Fees, Merck Partnership

11/7/07 View all Trade Related Articles > | Pharmalicensing.com - UK

Tuesday, October 30, 2007

Ariad Pharmaceuticals, Inc. News, Search Jobs, Events

10/30/07 View all Trade Related Articles > | BioSpace

Wednesday, October 10, 2007

ARIAD Pharmaceuticals reinitiated with "overweight"

10/10/07 | Newratings

1
Monday, August 24, 2009

Pre-Market Movers: Ariad Pharmaceuticals, Advanced Micro Devices

8/24/09 | Wichita Business Journal - Wichita KS

Wednesday, November 7, 2007

Ariad Pharmaceuticals' 3rd-quarter loss narrows on higher licensing fees, Merck partnership

11/7/07 View all Regional Related Articles > | CBS - CBS 11 - Dallas / Fort Worth TX

1
Thursday, November 5, 2009

ARIAD Reports Third Quarter 2009 Development Progress and Financial Results

11/5/09 | Business Wire

Monday, November 2, 2009

ARIAD’s AP24534 Featured in Cancer Cell Publication as a Potential First-in-Class Pan BCR-ABL Inhibitor

11/2/09 | Business Wire

Tuesday, October 27, 2009

ARIAD to Present at the Oppenheimer 20th Annual Healthcare Conference

10/27/09 | Business Wire

Thursday, October 22, 2009

ARIAD to Webcast Conference Call on Third Quarter 2009 Financial Results

10/22/09 | Business Wire

Monday, September 21, 2009

ARIAD Announces Clinical Data from Phase 1 Study of Its Investigational mTOR Inhibitor, Ridaforolimus, in Combination with Bevacizumab

9/21/09 | Business Wire

Monday, September 14, 2009

ARIAD Announces Result of First Interim Analysis of Phase 3 Succeed Trial of Oral Ridaforolimus, Its Investigational mTOR Inhibitor, in Metastatic Sarcomas

9/14/09 | Business Wire

Wednesday, September 2, 2009

ARIAD to Present at the Rodman & Renshaw Annual Healthcare Conference

9/2/09 | Business Wire

Friday, August 28, 2009

InvestorSoup.com Issues Technical Trading Outlook for ARIAD Pharmaceuticals Inc.

8/28/09 | GlobeNewswire

Monday, August 24, 2009

ARIAD And Its Co-Plaintiffs Announce That the Court of Appeals Granted Their Petition for Rehearing En Banc In the Lilly NF-kB Patent Lawsuit

8/24/09 | Business Wire

Thursday, August 6, 2009

Bellicum Pharmaceuticals Announces Initiation of Phase I/II Clinical Trial of Novel Vaccine for Patients With Advanced Prostate Cancer

8/6/09 | PR Newswire

Tuesday, August 4, 2009

ARIAD Prices Public Offering of Common Stock

8/4/09 | Business Wire

Monday, August 3, 2009

ARIAD Announces Proposed Public Offering of Common Stock

8/3/09 | Business Wire

Thursday, July 30, 2009

Ariad Reports Second Quarter 2009 Financial Results and Development Progress

7/30/09 | Business Wire

Beacon Equity Issues Trading Outlook for Ariad Pharmaceuticals Inc.

7/30/09 | GlobeNewswire

Tuesday, July 28, 2009

ARIAD Announces Preliminary Data from Two Ongoing Clinical Trials of Its Investigational mTOR Inhibitor, Ridaforolimus, in Combination with Targeted Drugs

7/28/09 | Business Wire

Monday, June 8, 2009

ARIAD Announces Webcast of Its Annual Stockholders Meeting

6/8/09 | Business Wire

Tuesday, June 2, 2009

ARIAD Announces Updates On NF-κB Patent Appeals

6/2/09 | Business Wire

Thursday, May 14, 2009

ARIAD to Present at Upcoming Meetings

5/14/09 | Business Wire

Thursday, May 7, 2009

ARIAD Reports First Quarter 2009 Development Progress and Financial Results

5/7/09 | Business Wire

Thursday, April 23, 2009

ARIAD to Webcast Conference Call on First Quarter 2009 Financial Results

4/23/09 | Business Wire

Tuesday, April 21, 2009

ARIAD Presents Novel Anti-Cancer Profile of Its Investigational Anaplastic Lymphoma Kinase (ALK) Inhibitor at AACR Meeting

4/21/09 | Business Wire

Monday, April 20, 2009

Preclinical Data Presented on ARIAD’s Investigational mTOR Inhibitor, Deforolimus, in Lung Cancer and Other Solid Tumor Models

4/20/09 | Business Wire

Monday, April 13, 2009

Preclinical Data on ARIAD's Oncology Pipeline to Be Presented at the AACR Annual Meeting

4/13/09 | Business Wire

Monday, April 6, 2009

ARIAD Appoints Former Bristol-Myers Squibb Senior Executive as New Independent Member of Its Board of Directors

4/6/09 | Business Wire

Friday, April 3, 2009

ARIAD Announces Court Rulings Regarding NF-κB Patent Lawsuit with Lilly

4/3/09 | Business Wire

Wednesday, March 11, 2009

ARIAD to Present at the 29th Annual Cowen Healthcare Conference

3/11/09 | Business Wire

Tuesday, March 3, 2009

ARIAD to Present at the Barclays Capital Global Healthcare Conference

3/3/09 | Business Wire

Monday, March 2, 2009

ARIAD Announces Start of Phase 2 Clinical Study of Oral Deforolimus in Patients with Advanced Non-Small Cell Lung Cancer

3/2/09 | Business Wire

Friday, February 20, 2009

ARIAD Announces $24.3 Million Registered Direct Financing

2/20/09 | Business Wire

Thursday, February 12, 2009

ARIAD Reports Financial Guidance for 2009 and Fourth Quarter and Year-End 2008 Financial Results

2/12/09 | Business Wire

Thursday, January 29, 2009

ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2008 Financial Results

1/29/09 | Business Wire

Tuesday, January 13, 2009

ARIAD Announces 2009 Key Corporate Objectives

1/13/09 | Business Wire

Thursday, January 8, 2009

ARIAD to Present at the 27th Annual J.P. Morgan Healthcare Conference

1/8/09 | Business Wire

Tuesday, January 6, 2009

ARIAD Expands Management Team with Executive Appointments in Regulatory Affairs, Manufacturing and Information Technology

1/6/09 | Business Wire

Tuesday, October 14, 2008

Beacon Equity Issues Technical Trade Alerts on Market Movers: VMED, ARIA, TXCO, IGTE, XIDE, JAVA

10/14/08 | PR Newswire

Thursday, June 5, 2008

ARIAD Announces Webcast of Its Annual Stockholders Meeting

6/5/08 | Business Wire

Wednesday, May 28, 2008

ARIAD Appoints Former Bristol-Myers Squibb Executive to Lead Corporate Legal and Compliance Functions

5/28/08 | Business Wire

Thursday, May 22, 2008

ARIAD Initiates Phase 1 Clinical Trial of its Investigational Oral Multi-Targeted Kinase Inhibitor, AP24534, in Patients with Hematological Cancers

5/22/08 | Business Wire

Thursday, May 15, 2008

ARIAD to Present Clinical Data at ASCO on the Anti-Tumor and Safety Profile of Its Oral Investigational mTOR Inhibitor, Deforolimus

5/15/08 | Business Wire

Wednesday, May 7, 2008

ARIAD Reports First Quarter 2008 Financial Results

5/7/08 | Business Wire

1
Monday, November 09, 2009

JP Morgan Upgrades Ariad Pharmaceuticals (ARIA) to Overweight

8:36:48 AM View all Blogs Related Articles > | StreetInsider.com

Thursday, November 5, 2009

ARIAD Pharma (ARIA) Posts Q3 Loss of 21c, Misses Views by 3c

11/5/09 | StreetInsider.com

Monday, November 2, 2009

Ariad Pharma (ARIA) Announced Publication of AP24534 in Scientific Journal Cancer Cell as a Premier Pan BCR-ABL Inhibitor

11/2/09 | StreetInsider.com

Thursday, October 8, 2009

Brean Murray Initiates Coverage on Ariad Pharmaceuticals (ARIA) with a Hold; Strong Fundamentals, Cautious on Phase 3 Trial

10/8/09 | StreetInsider.com

Monday, September 21, 2009

ARIAD Pharmaceuticals (ARIA) Announces Clinical Data from Phase 1 Study of Its Investigational mTOR Inhibitor, Ridaforolimus, in Combination with Bevacizumab

9/21/09 | StreetInsider.com

Monday, September 14, 2009

Live Updates:

Ticker

Dynamic view of the market

ARIAD PHARMACEUTICALS INC

ARIA

Stock price

Extended Hours

ARIAD PHARMACEUTICALS INC Real-Time Headlines

Monday, November 09, 2009

Friday, November 6, 2009

Thursday, November 5, 2009

Monday, November 2, 2009

Tuesday, October 27, 2009

Thursday, October 22, 2009

Tuesday, October 13, 2009

Thursday, October 8, 2009

Monday, October 5, 2009

Wednesday, September 23, 2009

Monday, September 21, 2009

Tuesday, September 15, 2009

Monday, September 14, 2009

Friday, September 4, 2009

Wednesday, September 2, 2009

Friday, August 28, 2009

Wednesday, August 26, 2009

Monday, August 24, 2009

Sunday, August 23, 2009

Tuesday, August 18, 2009

Monday, August 17, 2009

Wednesday, August 12, 2009

Monday, August 10, 2009

Saturday, August 8, 2009

Monday, August 3, 2009

Monday, November 09, 2009

Friday, November 6, 2009

Thursday, November 5, 2009

Tuesday, October 13, 2009

Thursday, October 8, 2009

Monday, October 5, 2009

Wednesday, September 23, 2009

Monday, September 14, 2009

Friday, September 4, 2009

Wednesday, August 26, 2009

Monday, August 24, 2009

Sunday, August 23, 2009

Tuesday, August 18, 2009

Monday, August 17, 2009

Wednesday, August 12, 2009

Monday, August 10, 2009

Saturday, August 8, 2009

Monday, August 3, 2009

Thursday, July 30, 2009

Tuesday, July 28, 2009

Monday, July 27, 2009

Wednesday, July 1, 2009

Monday, June 22, 2009

Monday, June 15, 2009

Wednesday, June 10, 2009

Tuesday, June 9, 2009

Friday, May 29, 2009

Thursday, May 14, 2009

Tuesday, September 15, 2009

Monday, August 3, 2009

Tuesday, July 28, 2009

Monday, July 27, 2009